124 related articles for article (PubMed ID: 32909167)
1. The impact of cognitive impairment on survival and medication adherence among older women with breast cancer.
Alatawi Y; Hansen RA; Chou C; Qian J; Suppiramaniam V; Cao G
Breast Cancer; 2021 Mar; 28(2):277-288. PubMed ID: 32909167
[TBL] [Abstract][Full Text] [Related]
2. Effects of breast cancer on chronic disease medication adherence among older women.
Santorelli ML; Steinberg MB; Hirshfield KM; Rhoads GG; Bandera EV; Lin Y; Demissie K
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):898-907. PubMed ID: 26875432
[TBL] [Abstract][Full Text] [Related]
3. Impact of preexisting mental illness on breast cancer endocrine therapy adherence.
Haskins CB; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA
Breast Cancer Res Treat; 2019 Feb; 174(1):197-208. PubMed ID: 30465157
[TBL] [Abstract][Full Text] [Related]
4. The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer.
Alatawi Y; Hansen RA; Chou C; Qian J; Suppiramaniam V; Cao G
Eur Geriatr Med; 2020 Dec; 11(6):1017-1026. PubMed ID: 32572725
[TBL] [Abstract][Full Text] [Related]
5. The influence of comorbidities on overall survival among older women diagnosed with breast cancer.
Patnaik JL; Byers T; Diguiseppi C; Denberg TD; Dabelea D
J Natl Cancer Inst; 2011 Jul; 103(14):1101-11. PubMed ID: 21719777
[TBL] [Abstract][Full Text] [Related]
6. Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.
Chou YT; Winn AN; Rosenstein DL; Dusetzina SB
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):676-684. PubMed ID: 28317314
[TBL] [Abstract][Full Text] [Related]
7. The impact of the introduction of generic aromatase inhibitors on adherence to hormonal therapy over the full course of 5-year treatment for breast cancer.
Ma S; Shepard DS; Ritter GA; Martell RE; Thomas CP
Cancer; 2020 Aug; 126(15):3417-3425. PubMed ID: 32484941
[TBL] [Abstract][Full Text] [Related]
8. The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer.
Winn AN; Dusetzina SB
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):953-9. PubMed ID: 27125337
[TBL] [Abstract][Full Text] [Related]
9. Endocrine adherence in male versus female breast cancer: a seer-medicare review.
Ali A; Xie Z; Stanko L; De Leo E; Hong YR; Bian J; Daily KC
Breast Cancer Res Treat; 2022 Apr; 192(3):491-499. PubMed ID: 35142938
[TBL] [Abstract][Full Text] [Related]
10. Survival benefits associated with being adherent and having longer persistence to adjuvant hormone therapy across up to five years among U.S. Medicare population with breast cancer.
Zheng D; Thomas J
Breast Cancer Res Treat; 2023 Aug; 201(1):89-104. PubMed ID: 37326766
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
[TBL] [Abstract][Full Text] [Related]
12. Influence of Traditional Chinese Medicine on Medical Adherence and Outcome in Estrogen Receptor (+) Breast Cancer Patients in Taiwan: A Real-World Population-Based Cohort Study.
Chan PW; Chiu JH; Huang N; Chen CM; Yu H; Liu CY; Hsu CH
Phytomedicine; 2021 Jan; 80():153365. PubMed ID: 33126168
[TBL] [Abstract][Full Text] [Related]
13. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.
Hershman DL; Tsui J; Wright JD; Coromilas EJ; Tsai WY; Neugut AI
J Clin Oncol; 2015 Mar; 33(9):1053-9. PubMed ID: 25691670
[TBL] [Abstract][Full Text] [Related]
14. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.
Li S; Liu J; Virnig BA; Collins AJ
Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451
[TBL] [Abstract][Full Text] [Related]
15. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
16. The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries.
Fisher KJ; Lee JH; Ferrante JM; McCarthy EP; Gonzalez EC; Chen R; Love-Jackson K; Roetzheim RG
Cancer; 2013 Aug; 119(16):2964-72. PubMed ID: 23677482
[TBL] [Abstract][Full Text] [Related]
17. The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence.
Winn AN; Fergestrom NM; Pezzin LE; Laud PW; Neuner JM
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):550-557. PubMed ID: 32196839
[TBL] [Abstract][Full Text] [Related]
18. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
20. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
